Leukemia

LEUKEMIA

FEATURE


LATEST ARTICLES


Median overall survival was 42 months in patients who received sorafenib and 13 months in patients who received chemotherapy alone.

Acute Myeloid Leukemia: What Your Patients Need to Know

Acute myeloid leukemia (AML) progresses more rapidly than other forms of leukemia. As such, if you or your patient are concerned they may have AML it is important to educate them on the symptoms and risk factors of the disease, as well as how to detect it and what treatments it could entail.
Next post in Leukemia